Opportunities in the Telemedicine Market in India
US$ 1,000.00
Executive
The telemedicine market in India has witnessed significant growth, owing to its potential of providing the world class clinical and medical services to distant and rural locations. The...
March 2012
30 pages
Merck - IMPROVE IT update - Appears trending favorably
US$ 90.00
Today, Merck announced that the Data Safety Monitoring Board has given a go-ahead signal to the IMPROVE-IT after it conducted a pre-specified second interim ... . The company has also indicated that the projected completion of IMPROVE IT by 2013 may change.
March 2012
1 pages
Medicated Skin Care in Argentina
US$ 990.00
... out of every 10 Argentine women in the country wear... Euromonitor International's Medicated Skin Care in Argentina report offers a comprehensive guide to the size and shape of the ... Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals ...
March 2012
30 pages
Medicated Skin Care in Estonia
US$ 990.00
Medicated skin care witnessed current value growth of 5% to reach EUR1.6 million in 2011 due to increased consumption. Consumers purchased medicated skin care products more freely in 2011 because ... decreased as well. Due to many positive factors, consumers’... Euromonitor International's Medicated Skin Care in Estonia report offers a comprehensive guide to the size and shape of the ...
March 2012
23 pages
Medicated Skin Care in Russia
US$ 990.00
... consultations with cosmetologists, trichologists and other professionals on... Euromonitor International's Medicated Skin Care in Russia report offers a comprehensive guide to the size and shape of the ... Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals ...
March 2012
43 pages
Fitness & Slimming Industry in India (2011-15)
US$ 500.00
EXECUTIVE SUMMARY
Indian Fitness & Slimming Industry constitutes about 8% of the wellness market. Presently, the fitness industry is in its nascent stages. The industry is fairly fragmented...
March 2012
48 pages
The Long Term Care Market: Nursing Homes, Home Care, Hospice Care, and Assisted Living
US$ 3,995.00
... . These twin challenges are addressed in The Long-Term Care Market: Nursing Homes, Home Care, Hospice Care, and Assisted Living The report ... the Marketplace Competitors and Competitive Analysis Sales estimates for each market segment represent U.S. revenues and are expressed in current dollars. Estimates ...
March 2012
185 pages
Medicated Skin Care in Lithuania
US$ 990.00
... little hesitation about spending on medicines recommended by a dermatologist. Euromonitor International's Medicated Skin Care in Lithuania report offers a comprehensive guide to the size and shape of the ... Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals ...
March 2012
27 pages
Medicated Skin Care in Denmark
US$ 990.00
Medicated skin care grew by 1% in 2011 to reach sales of DKr144 million. The positive growth stemmed from consumers’ increasing willingness to self-medicate and cure their skin ... ) treatments and cold sore treatments are skin conditions that most sufferers... Euromonitor International's Medicated Skin Care in Denmark report offers a comprehensive guide to the size ...
March 2012
32 pages
Medicated Skin Care in New Zealand
US$ 990.00
... hundreds of regulations that are considered to hinder business practice in New Zealand. With regard to medicated skin care, this review was intended to reduce compliance costs for ... Regulations Act 1984 as ‘a product that is primarily a food,... Euromonitor International's Medicated Skin Care in New Zealand report offers a comprehensive guide to the size and shape of the ...
March 2012
36 pages
Medicated Skin Care in Bolivia
US$ 990.00
... from. This trend continued to drive demand for medicated skin care products in 2011. Euromonitor International's Medicated Skin Care in Bolivia report offers a comprehensive guide to the size and ... and Allergy Remedies, Paediatric Digestive Remedies, Paediatric Medicated Skin Care, Pharyngeal Preparations, Standard Eye Care, Sticking Plasters/Adhesive Bandages, Systemic Analgesics, Topical ...
March 2012
30 pages
Medicated Skin Care in Bulgaria
US$ 990.00
... . Nizoral from Johnson & Johnson Bulgaria EOOD and Allergosan from Sopharma AD are the most popular brands in medicated skin care, and they retain their traditional popularity largely without significant marketing activities by their manufacturers. Euromonitor International's Medicated Skin Care in Bulgaria report offers ...
March 2012
24 pages
Regional Overview: Consumer Health Trends in Asia Pacific
US$ 2,000.00
... to gaining access to the largest region in the world. Euromonitor International’s Regional Overview: Consumer Health Trends in Asia Pacific global briefing examines the ... data. Why buy this report? Get a detailed picture of the Consumer Health market; Pinpoint growth sectors and identify factors driving ...
March 2012
59 pages
Orthobiologics: Global Market Prospects 2012-2022
US$ 2,635.00
... -2022 also examines the size and value of leading national/regional markets. For each of these, visiongain identifies prevailing trends and strategies that ... of companies and leading products. Why you should buy Orthobiologics: Global Market Prospects 2012-2022 In this report, you will receive the following ...
March 2012
123 pages
Galapagos - Partnership Impact Sustainable?
US$ 140.00
Though deal with Abbott has added credibility to Galapagos’ GLPG0634 (PhII, an oral JAK1 inhibitor), there is still ... by 2014 could elevate GLPG, but our analysis of the impact of catalysts for 2012-13 suggest that …. GLPG0634 will be ... report released on 6th March on GLPG titled “Partnership Impact Sustainable?”
March 2012
6 pages
GCC Healthcare Industry Overview
US$ 650.00
Description The GCC healthcare industry has witnessed a massive spurt in healthcare spend, expected to push the market to an estimated US$ 44 billion by 2015 and further to an estimated US$ 60 billio...
March 2012
61 pages
JAPAN DOMESTIC PHARMA- Competitive Landscape of Leading Therapy Classes - UPDATE
US$ 600.00
In this updated issue of ‘Japan-Domestic Pharma Market Summary’ for 2012, we present major 10 Thx Class in Japan which covers ~40% of total Japan domestic pharma market (~¥8.0 trillion). This will ... breakthroughs in each class – which includes products from all pharma companies operating in Japan including MNCs.
March 2012
27 pages
ROCHE - CHUGAI, RoActemra monotherapy Superior to Humira: ADACTA Study
US$ 90.00
In a Ph IV ADACTA monotherapy study, RoActema has shown superior improvement ... the biologic RA market (~ $10B). The data should support Roche’s sNDA for 1st line approval in the US (submitted in December ... in EU where Actemra is already approved in first line, Roche will file for a label change based on this data.
March 2012
2 pages
Surgical Apparel Market in the United States
US$ 200.00
... even less than models of the past. The surgical apparel market in United States has plenty of competition but the field is narrowing ... analyzes the Surgical Apparel Market in the United States in a comprehensive report which covers the basics of the market including market profile, market statistics, analysis ...
March 2012
20 pages
Orthopedic Orthotics: Market Research Report
US$ 4,200.00
This report analyzes the worldwide markets for Orthopedic Orthotics in US$ Million by the following Product Segments: Orthopedic Braces (Knee Braces, Ankle Braces, & ... NV, Ossur hf., Restorative Care of America, Inc., and Zimmer Holdings, Inc. Market data and analytics are derived from primary and secondary ...
February 2012
291 pages
Orthopedic Prosthetics: Market Research Report
US$ 4,500.00
This report analyzes the worldwide markets for Orthopedic Prosthetics in US$ Million by the following Product Segments: Hip Prosthesis, Knee Prosthesis, and ... Aesculap Implant Systems, Inc., Biomet, Inc., Corin Group PLC, DePuy Orthopedics, Inc., MatOrtho™ Ltd., DJO Surgical, Exactech, Inc., Smith & Nephew Plc ...
February 2012
353 pages
Laboratory Chemical Reagents: Market Research Report
US$ 4,950.00
This report analyzes the worldwide markets for Laboratory Chemical Reagents in US$ Million by the following Product Segments: Molecular Biology (Monoclonal & Polyclonal ... Biotech, Sigma-Aldrich Corp., Takara Bio, Inc., Wako Pure Chemical Industries Ltd., and Waters Corp. Major Monoclonal and Polyclonal ...
February 2012
815 pages
Breath Analyzers: Market Research Report
US$ 4,500.00
This report analyzes the worldwide markets for Breath Analyzers in Thousands of US Dollars by the following End-Use Segments: Regulatory Authorities, Employee ... , Inc., PAS Systems International, Inc., Paladin Labs Inc., and Q3 Innovations, LLC. Market data and analytics are derived from primary and secondary ...
February 2012
162 pages
L-Carnitine: Market Research Report
US$ 4,200.00
This report analyzes the worldwide markets for L-Carnitine in US$ Thousand. The report provides separate comprehensive analytics for the US, Canada, Japan, ... Technology Development Co., Ltd., and Zhejiang Jiashan Chengda Pharm & Chem Co., Ltd. Market data and analytics are derived from primary and secondary ...
February 2012
209 pages
Indian Hospital Services Market Outlook
US$ 800.00
The hospital services’ market represents one of the most lucrative segments of the Indian healthcare industry. Various factors, such as increasing prevalence of diseases, improving affordability, and...
February 2012
100 pages
Engaging KOLs: new thinking on thought leader development
US$ 595.00
Key opinion leaders (KOLs) play a vital role in the effective development and marketing of drugs and medical devices.
However, restrictions are increasingly being imposed on the ways in which...
February 2012
58 pages
New Thinking in Patient Adherence
US$ 695.00
Patient non-adherence is estimated to represent $290 billion per year in avoidable medical expenses in the United States alone. Consumers’ motivations for non-compliance are complex; up to 80% of peop...
February 2012
62 pages
U.S. Market for Pediatric Guided Growth Systems
US$ 2,995.00
... had been the gold standard for treating angular deformities; however, pediatric guided growth systems (PGGS) are quickly gaining popularity. Various deformities ... and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report ...
February 2012
11 pages
Bristol-Myers Squibb - Eliquis: FDA Decision Date Extended by Three Months
US$ 90.00
... BMY, the USFDA has extended the review period for Eliquis by 3 months (new PDUFA June 28th). At this ... has not announced any advisory committee to discuss Eliquis approval, but one may not rule out ... concerns over safety of Dabigatran. This delay in Eliquis approval, will obviously give some additional time for ...
February 2012
2 pages
Medicated Skin Care in China
US$ 990.00
Medicated skin care is one of the most important OTC categories in China, with sales value reaching RMB7.7 billion in 2011, up by 11% from 2010. ... rural areas in China, coupled with negative environmental factors, drove medicated skin care sales over the review period. Euromonitor International's Medicated Skin Care in China report offers a comprehensive ...
February 2012
49 pages
GALAPAGOS - Santa Arrives – Late but With Bounty!
US$ 90.00
Today’s exclusive global agreement of Galapagos’ (GLPG) GLPG0634 (PhII, RA, oral JAK1 inhibitor) with a veteran player in ... , please read our report released on 29th February on GLPG titled “Santa Arrives – Late but With Bounty!”
February 2012
3 pages
Medicated Skin Care in Canada
US$ 990.00
... with their day-to-day health concerns. Additionally, a... Euromonitor International's Medicated Skin Care in Canada report offers a comprehensive guide to the size and shape of the ... and Allergy Remedies, Paediatric Digestive Remedies, Paediatric Medicated Skin Care, Pharyngeal Preparations, Standard Eye Care, Sticking Plasters/Adhesive Bandages, Systemic Analgesics, Topical ...
February 2012
34 pages
Medicated Skin Care in Chile
US$ 990.00
... in 2010 was the highest in the review period. Euromonitor International's Medicated Skin Care in Chile report offers a comprehensive guide to the size and shape of the ... and Allergy Remedies, Paediatric Digestive Remedies, Paediatric Medicated Skin Care, Pharyngeal Preparations, Standard Eye Care, Sticking Plasters/Adhesive Bandages, Systemic Analgesics, Topical ...
February 2012
27 pages
DAIICHI SANKYO - Growth Story Remains Intact!
US$ 90.00
... rating on Daiichi Sankyo (DS) while revising down 12-months TP to ¥1,850 on account of incorporating likely impact of Ranbaxy settlement cost and tax reforms in Japan. Going forward ...
February 2012
2 pages
RANBAXY - Teva Partnership Hurts
US$ 140.00
... the unexpectedly high payment of ~$150m to Teva under the Lipitor generic agreement. Ranbaxy generated ~$300m from generic Lipitor that ... (1) Daiichi-Ranbaxy likely to become the largest generic company in Japan generics market (2) leveraging of Ranbaxy’s emerging market infrastructure (especially India) to ...
February 2012
6 pages
VIVUS: Potential for Adding More Weight in April
US$ 140.00
... safety profile. With the risk of generics, commercial potential of Avanafil worth... The upside could be more in case of a buyout, favorable licensing deal, ... approval time in April… For more details, please read our report released on February 24, 2012 on VVUS, titled “Potential for Adding More Weight in April”
February 2012
9 pages
Medicated Skin Care in Australia
US$ 990.00
Value growth of 4% in medicated skin care in 2011 was largely generated by changes in Australia’s demographic mix, particularly in relation to age. Succinctly, growth was driven by ... grew by 8%, making nappy rash the fastest growing niche in medicated skin care. Euromonitor International's Medicated Skin Care in Australia report offers a comprehensive guide to the size and shape ...
February 2012
34 pages
Medicated Skin Care in Indonesia
US$ 990.00
... awareness of the presence of some medicated skin care products to treat their conditions in the first place. Euromonitor International's Medicated Skin Care in Indonesia report offers a comprehensive guide to the ... and Allergy Remedies, Paediatric Digestive Remedies, Paediatric Medicated Skin Care, Pharyngeal Preparations, Standard Eye Care, Sticking Plasters/Adhesive Bandages, Systemic Analgesics, Topical ...
February 2012
35 pages
REGENERON: Marching Towards Profitability!
US$ 140.00
... Lucentis)! REGN should finally evolve from a Rising Star to become a profitable Biotech from 2012 onwards on the strength of its pipeline and ... , please read our report released on February 17, 2012 on REGN, titled “Marching Towards Profitability!”
February 2012
8 pages
Medicated Skin Care in Azerbaijan
US$ 990.00
... within this area. Consequently, many consumers began to use medicated skin... Euromonitor International's Medicated Skin Care in Azerbaijan report offers a comprehensive guide to the size and shape ... and Allergy Remedies, Paediatric Digestive Remedies, Paediatric Medicated Skin Care, Pharyngeal Preparations, Standard Eye Care, Sticking Plasters/Adhesive Bandages, Systemic Analgesics, Topical ...
February 2012
28 pages
Medicated Skin Care in Uruguay
US$ 990.00
... medicated skin care products at a good and steady pace, producing sustained growth in volume and value sales across most of the category. Euromonitor International's Medicated Skin Care in Uruguay ... and Allergy Remedies, Paediatric Digestive Remedies, Paediatric Medicated Skin Care, Pharyngeal Preparations, Standard Eye Care, Sticking Plasters/Adhesive Bandages, Systemic Analgesics, Topical ...
February 2012
21 pages
